Linagliptin approved for type 2 diabetes.

  title={Linagliptin approved for type 2 diabetes.},
  author={Kate Traynor},
  journal={American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists},
  volume={68 12},
Linagliptin approved for type 2 diabetes FDA on May 2 approved linagliptin, a dipeptidyl peptidase-4 inhibitor, for the improvement of blood glucose control in adults with type 2 diabetes mellitus. The drug is available under the brand name Tradjenta by Boehringer Ingelheim and Eli Lilly and Company, which earlier this year formed an alliance to develop new… CONTINUE READING